Steven Theriault
Chief Executive Officer at CYTOPHAGE TECHNOLOGIES LTD.
Net worth: - $ as of 30/04/2024
Profile
Steven Theriault is currently the Chief Executive & Science Officer, Director at Cytophage Technologies Ltd.
He previously held the position of Chief Executive & Science Officer at Cytophage Technologies, Inc. (Old).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 02/02/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Steven Theriault active positions
| Companies | Position | Start |
|---|---|---|
| CYTOPHAGE TECHNOLOGIES LTD. | Chief Executive Officer | 08/02/2024 |
Former positions of Steven Theriault
| Companies | Position | End |
|---|---|---|
Cytophage Technologies, Inc. (Old)
 Cytophage Technologies, Inc. (Old) BiotechnologyHealth Technology Cytophage Technologies, Inc. is a Canadian biotech company that produces bacteriophages, which are organisms that infect and kill bacterial cells. Cytophage is based in Winnipeg, Canada, and Steven Theriault has been the CEO of the private company since 2017. The company's tailor-made bacteriophages are inexpensive, quick to produce, harmless to humans and animals, better for the environment, and highly effective against exposed bacteria. The company is working on a phage nasal spray that goes directly to the area where the SARS-CoV-2 virus infects the body, the mucosal membranes in the nose and throat, to promote the production of antibodies through an adaptive immune response, giving protection from infection. Cytophage's bacteriophages have countless applications in food safety, animal health, and human health, and can be used for the decontamination of hospital surfaces and counters, tools and instruments, beds and curtains, and anywhere else bacterial contamination is a concern. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CYTOPHAGE TECHNOLOGIES LTD. | Finance |
| Private companies | 1 |
|---|---|
Cytophage Technologies, Inc. (Old)
Cytophage Technologies, Inc. (Old) BiotechnologyHealth Technology Cytophage Technologies, Inc. is a Canadian biotech company that produces bacteriophages, which are organisms that infect and kill bacterial cells. Cytophage is based in Winnipeg, Canada, and Steven Theriault has been the CEO of the private company since 2017. The company's tailor-made bacteriophages are inexpensive, quick to produce, harmless to humans and animals, better for the environment, and highly effective against exposed bacteria. The company is working on a phage nasal spray that goes directly to the area where the SARS-CoV-2 virus infects the body, the mucosal membranes in the nose and throat, to promote the production of antibodies through an adaptive immune response, giving protection from infection. Cytophage's bacteriophages have countless applications in food safety, animal health, and human health, and can be used for the decontamination of hospital surfaces and counters, tools and instruments, beds and curtains, and anywhere else bacterial contamination is a concern. | Health Technology |
- Stock Market
- Insiders
- Steven Theriault
